Search for: "Reading et al v. Pfizer Inc et al"
Results 21 - 35
of 35
Sorted by Relevance
|
Sort by Date
5 Apr 2013, 8:07 am
Pfizer, Inc., et al., No. 5:11-CV-69-DCB-JMR, 2013 U.S. [read post]
1 Apr 2015, 4:30 am
Target Corp. et al., 2015 Il. [read post]
14 Mar 2013, 4:00 am
” otherwise “. . . the court may be heading into unknown waters without a chart.[429] An example of an application of this reading of Free World can be found in Pfizer Canada Inc. v. [read post]
5 Mar 2010, 9:10 pm
Pfizer, Inc. v. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
3 Mar 2010, 5:05 am
Assistance Publique - Hopitaux De Paris et al. [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
23 Jan 2013, 1:02 am
United States Court of Appeals FOR THE DISTRICT OF COLUMBIA CIRCUIT Argued October 16, 2012 Decided January 22, 2013 No. 11-1265 AMERICANS FOR SAFE ACCESS, ET AL., PETITIONERS v. [read post]
17 May 2011, 10:37 pm
WO 01/08661 to Maloney ("Maloney"), both alone and in combination with United States Patent No. 5,047,248 to Calanchi et al. [read post]
17 Mar 2020, 1:32 pm
LeadCare® Test Kits have been recalled by Meridian Bioscience, Inc. due to a risk of inaccurate readings. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
29 Dec 2010, 12:54 pm
Wyeth, Inc. v. [read post]
13 Apr 2014, 8:59 am
Apotex Inc. v. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
2 Apr 2012, 6:15 am
(In case you’re wondering, the remaining five are Microsoft, Pfizer, Exxon-Mobil, Johnson & Johnson and ADP.) [read post]